Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

By Karabulut S.   Duranyıldız D.   Tas F.   Gezer U.   Akyüz F.   Serilmez M.   Ozgür E.   Yasasever C.   Vatansever S.   Aykan N.  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2729-2739

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma

By Ekman Simon   Fröödin Jan-Erik   Harmenberg Johan   Bergman Antonina   Hedlund ÅÅsa   Dahg Pia   Alvfors Carina   Stååhl Birgitta   Bergströöm Stefan   Bergqvist Michael  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 441-447

Informa Healthcare

Access to resources Recommend Favorite

Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy

By              

Oncology Reports, Vol. 32, Iss. 4, 2014-01 ,pp. : 1601-1609

Spandidos Publications

Access to resources Recommend Favorite

Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma

By Hartog Hermien  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 725-736

Springer Publishing Company

Access to resources Recommend Favorite

Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma

By Rasmuson T.   Grankvist K.   Jacobsen J.   Ljungberg B.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2199-2203

Elsevier

Access to resources Recommend Favorite